Michael A. Metzger - 07 Jul 2022 Form 4 Insider Report for CTI BIOPHARMA CORP

Role
Director
Signature
/s/ Bruce Seeley, attorney-in-fact for Michael A. Metzger
Issuer symbol
N/A
Transactions as of
07 Jul 2022
Net transactions value
-$130,995
Form type
4
Filing time
11 Jul 2022, 16:51:10 UTC
Previous filing
08 Jul 2022
Next filing
27 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTIC common stock Sale $58,500 -9,000 -45% $6.50 11,121 07 Jul 2022 Direct F1
transaction CTIC common stock Sale $38,409 -5,900 -53% $6.51 5,221 07 Jul 2022 Direct F1
transaction CTIC common stock Sale $21,653 -3,321 -64% $6.52 1,900 07 Jul 2022 Direct F1
transaction CTIC common stock Sale $2,612 -400 -21% $6.53 1,500 07 Jul 2022 Direct F1
transaction CTIC common stock Sale $2,616 -400 -27% $6.54 1,100 07 Jul 2022 Direct F1
transaction CTIC common stock Sale $7,205 -1,100 -100% $6.55 0 07 Jul 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.